Vertex Pharmaceuticals
VRTX
VRTX
643 hedge funds and large institutions have $35.9B invested in Vertex Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 99 funds opening new positions, 259 increasing their positions, 205 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
643
Holders Change
+33
Holders Change %
+5.41%
% of All Funds
14.6%
Holding in Top 10
10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-23.08%
% of All Funds
0.23%
New
99
Increased
259
Reduced
205
Closed
60
Calls
$206M
Puts
$225M
Net Calls
-$19.4M
Net Calls Change
-$73.6M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$279M |
| 2 |
Renaissance Technologies
New York
|
+$222M |
| 3 |
HM
HealthCor Management
New York
|
+$103M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$92.7M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$86.8M |
